Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Imidazole derivatives used as TAFIa inhibitors
Statistical identification of instances during reconciliation process
Multi currency exchanges between participants
Method and system for filtering noises in an image scanned by charged particles
RF/optical shared aperture for high availability wideband communication RF/FSO links
Methods and apparatus for processing audio signals
  Randomly Featured Patents
Method for forming a wiring metal layer in a semiconductor device
Microwave oven with bread toaster
Magnetic attachment for filtering oil
Mobile feeder system
Etherification process
Quaternary alkynoxymethyl amines
Dual protocol input device
Method and apparatus for determining characteristics of subsurface earth formations